ALEXANDER DUFFY: Open Payments
NPI 1053774257 · LEWISBERRY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,597 in 140 payments from 27 companies in 2025. Trend: 2023 $3,930 · 2024 $3,460 · 2025 $2,597
Food & beverage: $2,597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $521 |
| Novo Nordisk Inc | 24 | $325 |
| GlaxoSmithKline, LLC. | 14 | $257 |
| PFIZER INC. | 11 | $177 |
| AstraZeneca Pharmaceuticals LP | 8 | $177 |
| Exact Sciences Corporation | 6 | $176 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Lilly USA, LLC | 5 | $96 |
| Sumitomo Pharma America, Inc. | 1 | $86 |
| Axsome Therapeutics, Inc. | 4 | $74 |
Products named: Wegovy, VRAYLAR, TRELEGY ELLIPTA, UBRELVY, QULIPTA, ELIQUIS, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across PA — which companies pay providers there.
